SCHEMBL4462450

SCHEMBL4462450

NCC(=O)NCCc1cccnc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.56
HDAC2 Q92769 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
CHRNA7 P36544 1/20 0.54
CYP3A4 P08684 3/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C9 P11712 2/20 0.54
RECQL P46063 1/20 0.54
CYP2A6 P11509 1/20 0.51
CYP2C19 P33261 1/20 0.51
EPHX2 P34913 1/20 0.50
MAPT P10636 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18381213 0.89 CYP3A4 (0.60) HDAC8HDAC2HDAC6MEN1KMT2A
SCHEMBL16610103 0.87 CYP3A4 (0.61) HDAC8HDAC2HDAC6MEN1KMT2A
SCHEMBL18381201 0.85 CYP3A4 (0.67) HDAC8HDAC2HDAC6MEN1KMT2A
SCHEMBL12313357 0.84 HDAC2 (0.56) HDAC8HDAC2HDAC6MEN1KMT2A
SCHEMBL2755854 0.84 RECQL (0.71) HDAC8HDAC2HDAC6MEN1KMT2A
SCHEMBL1274303 0.84 RECQL (0.71) KMT2ASMN1; SMN2CYP3A4CYP1A2CYP2C9
SCHEMBL25784651 0.83 HDAC2 (0.61) HDAC8HDAC2HDAC6MEN1KMT2A
SCHEMBL3558312 0.82 MEN1 (0.63) HDAC8HDAC2HDAC6MEN1KMT2A
SCHEMBL30208757 0.82 MEN1 (0.63) HDAC8HDAC2HDAC6MEN1KMT2A
SCHEMBL16353647 0.82 TBXAS1 (0.61) MEN1KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed
WO-2008124085-A2 METHODS OF USING COMBINATIONS OF MEK AND JAK-2 INHIBITORS EXELIXIS, INC. (US) 2008-10-16 WO claimed